Showing 7951-7960 of 18164 results for "".
Management of HER2-Low MBC Following First-Line Disease Progression
https://reachmd.com/programs/cme/management-of-her2-low-mbc-following-first-line-disease-progression/29834/Join our expert faculty as they review the current guidelines for breast cancer and the clinical trial data supporting these recommendations.Beyond the Colonoscopy: New Screening Guidelines for Colorectal Cancer
https://reachmd.com/programs/project-oncology/beyond-colonoscopy-new-screening-guidelines-colorectal-cancer/9515/Dr. John Kisiel explores updated screening guidelines and novel methods for detecting colorectal cancer.Bladders, Breakthroughs, and Bold New Therapies: Key Updates at AUA 2025
https://reachmd.com/programs/clinicians-roundtable/bladders-breakthroughs-and-bold-new-therapies-key-updates-at-aua-2025/33040/In an exciting time for diagnostics and therapeutics in urology, the discussions at the American Urological Association’s 2025 Annual Meeting are redefining the landscape of men’s health. Dr. Wayne Kuang, CEO of MD for Men in Albuquerque and Founder of the ManVsProstate campaign, highlights some ofBalancing Risk and Benefit: Traditional MG Treatments and Medications to Avoid
https://reachmd.com/programs/cme/balancing-risk-and-benefit-traditional-mg-treatments-and-medications-to-avoid/32240/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.Lupus Management Considerations for African American Patients
https://reachmd.com/programs/everyday-family-medicine/lupus-management-considerations-for-african-american-patients/10132/With more African Americans experiencing severe lupus symptoms, Drs. Jennifer Caudle and Ashira Blazer provide some much-needed treatment advice.Applying CBT for Psychosis in Schizophrenia Care: Strategies for Expanding Access
https://reachmd.com/programs/neurofrontiers/applying-cbt-for-psychosis-in-schizophrenia-care-strategies-for-expanding-access/36647/Despite decades of evidence supporting cognitive behavioral therapy (CBT) for psychosis, most patients with schizophrenia in the U.S. never receive it due to systemic barriers like provider shortages and fragmented transitions after hospitalization. To address these gaps, Dr. David Kimhy joins Dr. CNavigating Nail Psoriasis: Treatment Strategies for Patient-Centered Care
https://reachmd.com/programs/clinicians-roundtable/navigating-nail-psoriasis-treatment-strategies-for-patient-centered-care/32867/Explore expert recommendations and long-term management strategies for nail psoriasis.Treatment of OAB and the Managed Care Professional: Balancing the Double-Edged Sword
https://reachmd.com/programs/cme/treatment-of-oab-and-the-managed-care-professional-balancing-the-double-edged-sword/15362/Are you prepared to actively engage with your patients about their overactive bladder?Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
https://reachmd.com/programs/neurofrontiers/rozanolixizumab-for-myasthenia-gravis-an-alternative-to-corticosteroids/30069/Here’s how rozanolixizumab compares to other treatment options for myasthenia gravis.Exploring Lateral Wall Collapse and Hypoglossal Nerve Stimulation in OSA
https://reachmd.com/programs/clinicians-roundtable/exploring-lateral-wall-collapse-and-hypoglossal-nerve-stimulation-in-osa/35654/A recent study explored whether lateral wall collapse can predict hypoglossal nerve stimulation efficacy in patients with obstructive sleep apnea (OSA). Join Dr. Daniel Vena as he explains the findings from this research and areas for future explanation. Dr. Vena is an Assistant Professor of Medicin